Bulletin
Investor Alert

Market Pulse Archives

Jan. 12, 2021, 8:16 a.m. EST

Uber, Moderna to collaborate on supporting COVID-19 vaccine uptake

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Uber Technologies Inc. (UBER)
  • X
    Moderna Inc. (MRNA)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Uber Technologies Inc. /zigman2/quotes/211348248/composite UBER -3.71% and Moderna Inc. /zigman2/quotes/205619834/composite MRNA +20.57% said Tuesday they will collaborate to explore ways to support the uptake of COVID-19 vaccines. The ridesharing and delivery company and the biotech said they will work together to provide "credible information" on vaccine safety through Uber's in-app messaging, and will look to identify opportunities to broaden access to COVID-19 vaccines. Moderna's COVID-19 vaccine was authorized in December for emergency use by the Food and Drug Administration, along with a vaccine from Pfizer Inc. /zigman2/quotes/202877789/composite PFE +6.11% and BioNTech SE /zigman2/quotes/214419716/composite BNTX +14.19% , but the administration of the vaccines has fallen well short of expectations. "As part of our commitment to help address COVID-19, Moderna will be working with a coalition of partners to educate, build trust around and increase awareness of the importance of vaccination in those communities significantly impacted by the pandemic," said Moderna Chief Executive Stéphane Bancel. "We look forward to combining our expertise with Uber's capabilities and platform to support this important effort." Uber's stock rose 1.5% in premarket trading Tuesday and Moderna shares advanced 0.8%, while futures /zigman2/quotes/209948968/delayed ES00 -0.36% for the S&P 500 /zigman2/quotes/210599714/realtime SPX -2.27% edged up 0.2%.

/zigman2/quotes/211348248/composite
US : U.S.: NYSE
$ 40.52
-1.56 -3.71%
Volume: 35.45M
Nov. 26, 2021 1:10p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$78.61 billion
Rev. per Employee
$488,553
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 329.63
+56.24 +20.57%
Volume: 35.90M
Nov. 26, 2021 1:00p
P/E Ratio
20.24
Dividend Yield
N/A
Market Cap
$133.65 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 54.00
+3.11 +6.11%
Volume: 66.56M
Nov. 26, 2021 1:10p
P/E Ratio
16.03
Dividend Yield
2.89%
Market Cap
$303.09 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 348.00
+43.24 +14.19%
Volume: 11.03M
Nov. 26, 2021 1:00p
P/E Ratio
10.05
Dividend Yield
N/A
Market Cap
$84.40 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/209948968/delayed
US : U.S.: CME
$ 4,579.00
-16.75 -0.36%
Volume: 1.98M
Nov. 26, 2021 12:14p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,594.62
-106.84 -2.27%
Volume: 2.10B
Nov. 26, 2021 2:12p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.